Statin Drug Scandal: Cholesterol-lowering Drug Researchers Start Backtracking

‘The cholesterol-lowering statin drug empire continues to crumble. This past Sunday (February 15, 2015) the Sunday Express in the UK published a headline story stating that Oxford professor Dr. Rory Collins, whose research had been used to support putting millions of patients on statin drugs, was reassessing the data behind those studies for possible drug side effects they might have missed previously.

According to the Express:

Although the original research looked at the effect of statins on the heart and considered cancer risks it did not examine other side effects.

This announcement by Dr. Collins is stunning, to say the least, and points to a massive cover-up and scandal related to statin drugs.’

Read more: Statin Drug Scandal: Cholesterol-lowering Drug Researchers Start Backtracking